[LGND] YoY Quarter Result on 30-Sep-2006 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
14-Nov-2006
Financial Year
2006
Quarter
30-Sep-2006 [#Q3]
Profit Trend
QoQ- 6.52%
YoY- -137.51%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 CAGR
Revenue 7,802 7,901 5,248 5,479 36,707 42,584 49,497 -26.49%
PBT -11,436 1,055 -6,134 -7,222 -16,969 -6,264 -4,125 18.51%
Tax 419 -748 2,990 -2,360 -828 17 2,904 -27.56%
NP -11,843 1,803 -18,125 1,248 -14,918 -6,281 -6,789 9.71%
Tax Rate - 70.90% - - - - - -
Total Cost 19,645 6,098 23,373 4,231 51,625 48,865 56,286 -16.08%
Ratio Analysis
30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 CAGR
NP Margin -151.79 22.82 -345.37 22.78 -40.64 -14.75 -13.72 49.24%
Per Share
30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 CAGR
EPS -0.60 0.12 -1.14 0.06 -1.14 -0.51 -0.55 1.46%
EPS Diluted -0.60 0.12 -1.14 0.06 -1.14 -0.51 -0.55 1.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.